Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-009627
Filing Date
2017-04-06
Accepted
2017-04-06 08:27:59
Documents
2
Period of Report
2017-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4061
2 EX-24 DOCUMENT attachment1.htm EX-24 4439
  Complete submission text file 0000899243-17-009627.txt   10085
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Reporting) CIK: 0001364719 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 17744456